期刊文献+

硼替佐米治疗多发性骨髓瘤导致肺损害及心力衰竭一例并文献复习 被引量:4

原文传递
导出
摘要 目的分析接受硼替佐米治疗多发性骨髓瘤(MM)患者的不良反应。方法回顾性分析1例初治MM患者接受硼替佐米治疗后同时发生严重肺损害、心力衰竭的情况,并复习文献。结果硼替佐米相关性肺损害、心力衰竭多发生于多次治疗后,与心肺基础状况有关,也可发生于初治患者,糖皮质激素治疗有效。结论硼替佐米相关性肺损害、心力衰竭发生率低,但预后差、死亡率极高。疑诊患者应及早给予糖皮质激素治疗及高流量氧疗。
出处 《白血病.淋巴瘤》 CAS 2012年第7期435-437,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献18

  • 1Voortman J, Giaccone G. Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. BMC Cancer, 2006, 6:129.
  • 2Boyer JE, Batra RB, Ascensao JL, et al. Severe pulmonary complication after bortezomib treatment for multiple myeloma. Blood, 2006,108 : 1113.
  • 3Gotoh A, Ohyashiki K, Oshimi K,et al. Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "lung injury by bortezomib" joint committee of the Japanese society of hematology and the Japanese society of clinical hemalology. IntJ Hematol,2006, 84:406-412.
  • 4Pitini V, A1Tigo C, Ahavilla G, et al. Severe pulmonary complications after bortezomib treatment for multiple myeloma. Leuk Res, 2007,31 : 1027-1028.
  • 5Ohri A, Arena FP. Severe pulmonary complications in African- American patient after bortezomib therapy. Am J Ther ,2006, 13 553-555.
  • 6Zhou X, Sun C, Wang J, et al. Rapid fatal pulmonary complications in a Chinese patient after borlezomib treatment for ALK-negative anaplastie large-cell lymphoma. Clin Lymphoma Myeloma Leuk, 2010, 10:152-154.
  • 7顿晓熠,袁振刚,傅卫军,侯健.硼替佐米治疗多发性骨髓瘤致五例患者严重肺损伤[J].中华血液学杂志,2010,31(4):259-261. 被引量:9
  • 8王亚非,邱录贵,邹德慧,王迎,邓书会,李园,徐燕,钱林生,赵耀中.硼替佐米治疗多发性骨髓瘤后严重肺损伤二例报告并文献复习[J].白血病.淋巴瘤,2008,17(2). 被引量:12
  • 9龚明,马一盖.硼替佐米治疗难治性浆细胞疾病导致的肺损伤[J].临床肿瘤学杂志,2010,15(2):163-165. 被引量:1
  • 10闫涵,欧晋平,章巍,岑溪南,任汉云.硼替佐米致多发性骨髓瘤患者急性肺损伤一例[J].中华内科杂志,2011,50(6):517-518. 被引量:6

二级参考文献31

  • 1王亚非,邱录贵,邹德慧,王迎,邓书会,李园,徐燕,钱林生,赵耀中.硼替佐米治疗多发性骨髓瘤后严重肺损伤二例报告并文献复习[J].白血病.淋巴瘤,2008,17(2). 被引量:12
  • 2侯健,周帆,张永贞,景燕.硼替佐米治疗复发、难治性多发性骨髓瘤[J].中国新药与临床杂志,2005,24(7):579-581. 被引量:13
  • 3Jagannath S, Barlogie B, Berenson J, et al. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma[ J]. Br J Haematol,2004 ,127 : 165 - 172.
  • 4Richardson PG, Sonneveld P, Schuster MW, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma [ J ].N Engl J Med, 2005, 352:2487 -2498.
  • 5Ciolli S, Leoni F, Gigli F, et al. Low dose velcade, thalidomide and dexamethasone: an effective regimen for relapsed and refractory multiple myeloma patients [ J ]. Leuk Lymphoma, 2006,47 : 171 - 173.
  • 6Musto P, Rossini F, Gay F, et al. Efficacy and safety of bortezomib in patients with plasma cell leukemia[ J]. Cancer, 2007, 109:2285 - 2290.
  • 7Esparis-Ogando A, Alegre A, Aguado B, et al. Bortezomib is an efficient agent in plasma cell leukemias[ J]. Int J Cancer, 2005, 114:665 - 667.
  • 8Miyakoshi S, Kami M, Yuji K, et al. Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma[J]. Blood, 2006, 107:3492 -3494.
  • 9Ohri A, Arena F. Severe puhnonary complications in African-American patients after bortezomib therapy [ J ]. Am J Therapeutics, 2006, 13:553 - 555.
  • 10Pitini V, Arrigo C, Ahavilla G, et al. Severe puhnonary complications after bortezomib treatment for multiple myeloma: An unrecognized puhnonary vasculitis? [ J]. Leuk Res, 2007, 31 : 1023 - 1028.

共引文献13

同被引文献20

  • 1徐丹,刘启发,孙竞,范志平,魏永强,张钰,叶昌雄,孟凡义.异基因造血干细胞移植后迟发性非感染肺部并发症分析[J].中华医学杂志,2006,86(8):549-553. 被引量:7
  • 2施举红,严晓伟,许文兵,刘鸿瑞,朱元珏.药物性肺损伤的临床诊断与治疗[J].中华结核和呼吸杂志,2007,30(3):161-166. 被引量:14
  • 3金沢実,史春虹.药物性肺损害的危险因素及其预防[J].日本医学介绍,2007,28(3):104-107. 被引量:2
  • 4Camus P, Fanton A, Bonniaud P, et al. Interstitial lung disease induced by drugs and radiation. Respiration, 2004, 71: 301-326.
  • 5Ware LB, Matthay MA. Clinical practice. Acute pulmonary edema. N Engl J Med. 2005, 353:2788-2796.
  • 6Wheeler AP, Bernard GR. Acute lung injlary and the acute respiratory distress syndrome: a clinical review. Lancet, 2007, 369: 1553-1564.
  • 7Mercat A, Richard JC, Vielle B, et al. Positive end-expiratory pressuresetting in aduhs with acute lung injmy and acute respiratory distress syndrome: a randomized controlled trial. JAM& 2008, 299: 646-655.
  • 8Burton C, Kaczmarski R, Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy. N Engl J Med, 2003, 348:2690-2691.
  • 9Zayen A, Rais H, Rift H, et al. Rituximab-induced interstitial lung disease: case report and literature review. Pharmacology, 2011, 87: 318-320.
  • 10Ohnishi K, Sakai F, Kudoh S, et al. Twenty-seven cases of drug- induced inteI:stitial lung disease associated with imatinib mesylate. Leukemia, 2006, 20:1162-1164.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部